Conference Summary by Steere, Allen C.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 57 (1984), 711-713
Conference Summary
ALLEN C. STEERE, M.D.
Lyme disease was recognized as a separate entity in 1975 because of close
geographic clustering of affected children in Lyme, Connecticut, with what was
thought to be juvenile rheumatoid arthritis. It then became apparent that Lyme
disease is a complex, multisystem disorder. The illness usually begins with erythema
migrans (stage 1), and is sometimes followed by meningitis, peripheral neuritis, or
carditis (stage 2), or arthritis (stage 3). Although usually intermittent, the arthritis
may become chronic, with erosion of cartilage and bone. Erythema chronicum
migrans (ECM) was recognized in Europe in 1909, and this lesion was first linked to
subsequent neurologic involvement in 1922. There, the neurologic abnormalities
have been called different names, including Bannwarth's syndrome, chronic men-
ingitis, and tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth). Both ar-
thritis and carditis following ECM have now been described in Europe, but they are
rare. Conversely, two additional entities-lymphocytoma and acroder:natitis
chronica atrophicans-have been linked to ECM and Ixodes ricinus tick bites in
Europe, but an association with tick bites has not been recognized in the United
States. In general, the disease seems morevirulent inAmerica-multiple skin lesions
are more common, headache occurs more often with the meningitis, and arthritis is
a frequent feature of the disease-but the basic outlines of the illness are similar
both here and abroad. As is typical ofother spirochetal infections, Lyme disease oc-
curs in stages, with remissions and exacerbations and different clinical manifesta-
tions at each stage. For patients with early Lyme disease, tetracycline is the treat-
ment of choice, then penicillin, and finally erythromycin. High-dose intravenous
penicillin is effective for the later stages of Lyme disease. Studies of antibiotic sus-
ceptibilities in vitro suggest that oralantibiotic regimens may not always attain blood
levels necessary to kill the spirochete.
The causative spirochete ofLyme disease was found first in the tick vector, Ixodes
dammini. The organism was first seen in Giemsa-stained sections ofmidgut and was
then visualized by a darkfield microscopy. Soon thereafter, it was grown in forti-
fied Kelly's medium, a medium which supports the growth of borreliae. Important
factors in making the medium include the use of double-distilled water, boiling or
alkalinization of neopeptones, and the avoidance of certain mammalian sera that
may contain inhibitory factors. The organism grows best between 30 and 33°C.
Studies of morphology, biochemistry, and DNA relatedness have established that
the Lyme spirochete is a member of the genus Borrelia. Lyme spirochetes are 11 to
25 ,um long and have 7 to 11 flagellae. They lack the cytoplasmic tubules of
treponemes and have more flagellae than either treponemes or leptospires.
However, they have less sharply pointed cell ends and fewer flagellae than previ-
ously reported borreliae. Like borreliae, Lyme spirochetes are microaerophilic,
catalase-negative bacteria with a cytosine/guanine ratio of 27.3 to 30.5 percent.
However, the DNA homology between three previous Borrelia species and Lyme
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All rights of reproduction in any form reserved.spirochetes is only 31 to 59 percent, which suggests that the Lyme organisms are
newly recognized borreliae. In addition, certain monoclonal antibodies easily dis-
tinguish Lyme spirochetes from other borreliae. The DNA homology among dif-
ferent isolates of Lyme spirochetes is similar (76 to 100 percent), including isolates
from the United States and Europe. Thus, all current isolates are thought to belong
to the same species.
Lyme spirochetes are difficult to recover from patients. To date, of 154 patients
cultured, only six specimens have yielded spirochetes: four from blood, one from a
skin biopsy specimen ofECM, and one from cerebrospinal fluid. It has beenequally
difficult to visualize spirochetes in affected tissues using various stains. In contrast,
the determination of antibody titers is often helpful in diagnosis. The specific IgM
response is maximal three to six weeks after disease onset but may persist. The spe-
cific IgG response is often delayed for several weeks, but is almost always present
later. Although early insensitivity is still a problem, one can nearly always make a
serodiagnosis of Lyme arthritis. Serological cross-reactivity is rarely a problem;
VDRL is positive in syphilis but not in Lyme disease. Similar serologic results have
been found in European patients with erythema migrans and tick-borne menin-
gopolyneuritis. In addition, both lymphocytoma and acrodermatitis atrophicans
have been linked serologically to Lyme spirochetes. Currently, efforts areunder way
to identify antigenic polypeptides of the spirochete. As the disease progresses, pa-
tients develop an increasing array ofspecific antibodies against 6 to 12polypeptides.
Some components elicit antibodies from the majority of patients, but other com-
ponents, notably a 34,000 molecular weight polypeptide, are less commonly bound.
Studies attempting to unravel the pathogenesis of joint involvement of Lyme
disease are in progress. Since all attempts to culture or visualize spirochetes in
synovium have so far beenunsuccessful, it is not yet known whetherthespirochete is
still alive later in the disease when arthritis is present, and if so, where it is. Lyme
spirochetes may be phagocytosed by monocytes and polymorphonuclearleukocytes,
but it is not known whether the organisms may survive in monocytes. Circulating
immune complexes are found in patients early in the disease, and later tend to
localize in joints. There, the concentrations of complexes correlate positively with
the number of synovial fluid granulocytes. However, it is not yet known whether
spirochetal antigens are present in the complexes. Studies ofimmunoregulation have
shown that joint involvement is associated with less spontaneous suppressor cell
activity than normal and with heightened responsiveness of mononuclear cells to
the Lyme spirochete and to phytohemagglutinin (PHA), particularly in joint fluid.
These changes correlate directly with the total serum IgM level, which is the best
laboratory indicator ofdisease activity. It is possiblethat decreased suppression may
permit damage to host tissues by either autoimmune phenomena or a heightened
response to the Lyme spirochete. In an effort to better understand pathogenesis,
attempts have been made to find an animal model of Lyme disease. Some experi-
mentally infected rabbits have developed erythema migrans and have been spiro-
chetemic during the period of 10 to 20 days post-inoculation. However, the rabbits
have not developed the later manifestations of Lyme disease and thus seem only
marginally susceptible to the Lyme spirochete.
The principal vectors of Lyme disease are several closely related ixodid ticks-I.
dammini, L pacificus, and L ricinus. These ticks, which cycle through three
stages -larvae, nymph, and adult-are nearly identical morphologically, but have
certain behavioral differences. Immature I. dammini are quite aggressive and feed
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on many different animals including mice, other rodents, domestic animals, and
birds. The preferred host for immatures seems to be the deer mouse, Peromyscus
leucopus. Although all three stages of the tick may bite man, the host range of the
adult tick is narrower. Their preferred host is deer. Thus, it has been postulated that
deer are quite important in the life cycle of the tick, and the increased frequency of
the disease in the northeastern United States has been linked to the increased abun-
dance of deer. In most infected ticks, spirochetal development seems to be limited to
the midgut, and the spirochete is probably transmitted by regurgitation of infected
gut contents during feeding. Transovarial transmission appears to be unusual. Thus,
for horizontal transmission to occur, it has been postulated that P. leucopus serve as
the most important reservoir of the Lyme spirochete and are a necessary participant
in its life cycle. In support of this hypothesis, only nymphs and adults have been
found to be infected with the spirochete. Nymphs feed primarily in May through
July and infect the miceduring this period. Larvae feedprimarilyduringAugust and
are, in turn, infected by the mice. The spirochete has been recovered from P.
leucopus, deer, and certain birds, and antibody against the spirochete has been
found in a wide range of animals.
Lyme disease is now known to have a world-wide distribution that correlates
primarily with the range of these ixodid ticks. In the northeastern United States, L
dammini appear to have expanded from a single island location, Naushon Island,
since the 1940s and have invaded new sites as recently as the 1980s. Certain
islands-Nantucket, Martha's Vineyard, Cuttyhunk, and Shelter Island-appear to
have the heaviest infestations and in some of these locations, 50 to 100 percent of
ticks are infected with spirochetes. Additional areas with heavy infestations in the
Northeast include Cape Cod, southeastern Connecticut, Long Island, Westchester
county in New York, and central New Jersey. I. dammini are also found in Wiscon-
sin, Minnesota, and nearby Canada. In the West-California, Oregon, and
Utah-Lyme disease is transmitted by L pacificus, but in these areas, only about 3
percent of ticks are infected, and thus the disease is less common there. I. ricinus is
the vector throughout Europe and Scandinavia, but the illness has also been de-
scribed in Australia where ixodid ticks are not known to occur. Thus, it seems likely
that the Lyme spirochete may have other arthropod or insect vectors. The nymphal
stage of the tick seems to be primarily responsible for transmission of the disease,
and, therefore, most new cases in the northern hemisphere occur in June or July.
Patients of any age (2 to 88 years) and both sexes are affected.
Lyme disease has two central areas ofinterest and concern. First, although the ex-
act frequency of the illness is unknown, it is clear that hundreds of new cases of
Lyme disease occur each year. Thus, it is necessary for physicians to know how to
diagnose and treat the infection. For public health officials, it is important to con-
duct surveillance, provide serologic support, disseminate information, and to con-
sider methods of tick control. Second, Lyme disease has similarities to several
immune-mediated disorders ofunknown etiology including rheumatoid arthritis. In
the study of these diseases, Lyme disease has the advantage that the causative agent
is known. Thus, it is hoped that efforts to understand the pathogenesis of Lyme ar-
thritis may help in the understanding of other arthritides.
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